Equillium Files Definitive Proxy Statement for 2025 Shareholder Meeting
Ticker: EQ · Form: DEF 14A · Filed: Apr 10, 2025 · CIK: 1746466
| Field | Detail |
|---|---|
| Company | Equillium, INC. (EQ) |
| Form Type | DEF 14A |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Equillium's proxy statement is out for the May 21st meeting - vote your shares!
AI Summary
Equillium, Inc. filed its definitive proxy statement on April 10, 2025, for its annual meeting of stockholders scheduled for May 21, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of the independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual filing providing information to shareholders and does not indicate any immediate operational or financial risks.
Key Numbers
- 20250521 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
Key Players & Entities
- Equillium, Inc. (company) — Registrant
- 20250410 (date) — Filing Date
- 20250521 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the definitive proxy statement for Equillium, Inc.'s annual meeting of stockholders.
When is Equillium, Inc.'s annual meeting of stockholders scheduled?
Equillium, Inc.'s annual meeting of stockholders is scheduled for May 21, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 10, 2025.
What is the company's Standard Industrial Classification (SIC) code?
Equillium, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Equillium, Inc. headquartered?
Equillium, Inc. is headquartered at 2223 Avenida De La Playa, Suite 105, La Jolla, CA 92037.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 10, 2025 regarding Equillium, Inc. (EQ).